BeStock  
Stocks › Biotechnology › CTMX

CytomX CTMX

US equityMarket cap rank #3673Biotechnology
$2.55 −$0.01 (-0.39%)
Pre-market · Oct 8, 8:20 am ET · After hours $2.54 -0.39%
Open$2.53
Prev close$2.56
Day range$2.52 – $2.65
Volume2.34M
Market cap$555.64M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±19.6%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+129.4%
Worst reaction-51.3%

Stock move on the day after each report

-2.3%2023/Q3-14.3%2023/Q4-51.3%2024/Q1+1.7%2024/Q2+9.0%2024/Q3+7.7%2024/Q4+129.4%2025/Q1+11.9%2025/Q2-13.6%2025/Q3+44.2%2025/Q4-0.5%2026/Q1+2.7%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q26 Aug 2026After Market±17.1%+2.67%Within range
2026/Q17 May 2026After Market±10.6%-0.50%Within range
2025/Q416 Mar 2026Pre Market±55.8%+44.23%Within range
2025/Q36 Nov 2025After Market±30.4%-13.60%Within range
2025/Q27 Aug 2025After Market±29.1%+11.90%Within range
2025/Q112 May 2025Pre Market±58.6%+129.43%Bigger than priced
2024/Q46 Mar 2025After Market±40.5%+7.71%Within range
2024/Q37 Nov 2024After Market±25.0%+9.00%Within range
2024/Q28 Aug 2024After Market±33.9%+1.69%Within range
2024/Q18 May 2024After Market±50.7%-51.31%Bigger than priced
2023/Q411 Mar 2024After Market±27.9%-14.34%Within range
2023/Q37 Nov 2023After Market±72.7%-2.34%Within range
2023/Q28 Aug 2023After Market±53.3%-3.55%Within range
2023/Q19 May 2023After Market±52.3%+5.81%Within range
2022/Q427 Mar 2023After Market±50.3%-15.08%Within range
2022/Q38 Nov 2022After Market±89.4%+0.81%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$1.42M-92.4% YoY
Operating profit-$23.78M-1,749.2% YoY
Net profit-$20.67M-13,319.5% YoY
Diluted EPS-$0.09
Free cash flow-$18.07M-14.5% YoY
Operating cash flow-$18.07M

Revenue, last 8 quarters

$33.4MSep '24$38.1MDec '24$50.9MMar '25$18.7MJun '25$6.0MSep '25$663.0KDec '25$10.3MMar '26$1.4MJun '26

Net profit, last 8 quarters

$5.7MSep '24$18.9MDec '24$23.5MMar '25$-154.0KJun '25$-14.2MSep '25$-26.5MDec '25$-18.2MMar '26$-20.7MJun '26

Profitability & balance sheet

Operating margin-476.2%
Net margin-435.2%
Return on equity-37.8%
Return on assets-28.6%
Return on invested capital-38.8%
Current ratio9.36
Liabilities / assets20.8%
Cash & investments$330.28M
Total debt$4.21M
Net cash (debt)$326.07M

Discussion

No comments yet — be the first to weigh in on CTMX.

Leave a comment

Scroll to Top